We evaluate your individual risk factors before prescribing and monitor your health throughout treatment
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (harmony outcomes): a double-blind, randomised placebo-controlled trial
The root cause needs to be addressed through nutrition and supplementation rather than injection scheduling
In a recent study published in Nature, researchers developed the MK-801 bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models of metabolic illness by combining N-methyl-D-aspartate (NMDA) receptor antagonism with glucagon-like peptide-1 (GLP-1) receptor antagonism
doi: 10.1055/s-2004-826160 31 DeaconCFJohnsenAHHolstJJ
Beyond the numbers on the scale, success means being able to move your body more freely, play with your kids without getting tired, and feel proud of the healthy choices you're making every day